These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antiplatelet and antithrombotic activities of salvianolic acid A. Fan HY; Fu FH; Yang MY; Xu H; Zhang AH; Liu K Thromb Res; 2010 Jul; 126(1):e17-22. PubMed ID: 20451955 [TBL] [Abstract][Full Text] [Related]
23. Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors. Zhang DD; Linke B; Suo J; Zivkovic A; Schreiber Y; Ferreirós N; Henke M; Geisslinger G; Stark H; Scholich K Biol Chem; 2015 Jun; 396(6-7):783-94. PubMed ID: 25720064 [TBL] [Abstract][Full Text] [Related]
24. Thrombolytic effects of the snake venom disintegrin saxatilin determined by novel assessment methods: a FeCl3-induced thrombosis model in mice. Kwon I; Hong SY; Kim YD; Nam HS; Kang S; Yang SH; Heo JH PLoS One; 2013; 8(11):e81165. PubMed ID: 24260554 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of anti-platelet and anti-thrombotic effects of cilostazol with PFA-100® and Multiplate® whole blood aggregometer in vitro, ex vivo and FeCl3-induced thrombosis models in vivo. Kim CW; Yun JW; Bae IH; Park YH; Jeong YS; Park JW; Chung JH; Park YH; Lim KM Thromb Res; 2011 Jun; 127(6):565-70. PubMed ID: 21420150 [TBL] [Abstract][Full Text] [Related]
27. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model. Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban. Komatsu Y; Inoue Y; Goto Y; Fukazawa T; Hayashi H Thromb Haemost; 1999 Feb; 81(2):250-5. PubMed ID: 10064001 [TBL] [Abstract][Full Text] [Related]
30. New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation. Xiong J; Bai L; Fang W; Fu J; Fang W; Cen J; Kong Y; Li Y Eur J Pharm Sci; 2012 Apr; 45(5):552-8. PubMed ID: 22285483 [TBL] [Abstract][Full Text] [Related]
31. Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor. Trifilieff A; Fozard JR J Pharmacol Exp Ther; 2012 Aug; 342(2):399-406. PubMed ID: 22570366 [TBL] [Abstract][Full Text] [Related]
33. [Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats]. Xu HL; Feng YP Yao Xue Xue Bao; 2001 May; 36(5):329-33. PubMed ID: 12584852 [TBL] [Abstract][Full Text] [Related]
34. Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis. Son DJ; Lee HW; Shin HW; Lee JJ; Yoo HS; Kim TJ; Yun YP; Hong JT Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):383-90. PubMed ID: 18571912 [TBL] [Abstract][Full Text] [Related]
35. Diindolylmethane ameliorates platelet aggregation and thrombosis: In silico, in vitro, and in vivo studies. Ramakrishna K; Singh N; Krishnamurthy S Eur J Pharmacol; 2022 Mar; 919():174812. PubMed ID: 35151647 [TBL] [Abstract][Full Text] [Related]
36. Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease. van der Giet M; Tölle M; Kleuser B Biol Chem; 2008 Nov; 389(11):1381-90. PubMed ID: 18925828 [TBL] [Abstract][Full Text] [Related]
37. Sphingosine-1-phosphate and its mimetic FTY720 do not protect against radiation-induced ovarian fibrosis in the nonhuman primate†. Amargant F; Manuel SL; Larmore MJ; Johnson BW; Lawson M; Pritchard MT; Zelinski MB; Duncan FE Biol Reprod; 2021 May; 104(5):1058-1070. PubMed ID: 33524104 [TBL] [Abstract][Full Text] [Related]
38. Sphingosine 1-phospate differentially modulates maturation and function of human Langerhans-like cells. Bock S; Pfalzgraff A; Weindl G J Dermatol Sci; 2016 Apr; 82(1):9-17. PubMed ID: 26803226 [TBL] [Abstract][Full Text] [Related]
39. Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis. Wang J; Wang J; Lu P; Cai Y; Wang Y; Hong L; Ren H; Heng BC; Liu H; Zhou J; Ouyang H Biomaterials; 2015 Sep; 62():76-87. PubMed ID: 26036174 [TBL] [Abstract][Full Text] [Related]
40. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice. Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]